Generate Biomedicines, Inc. Common Stock (GENB)

Typically moves ±7.71% on earnings
EARNINGS ANALYTICS
search

Generate Biomedicines, Inc. Common Stock (GENB) has only 2 recorded earnings events on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was -4.27% (Aug 06, 2026) and its biggest decline was -11.14% (May 07, 2026).

Earnings reactions

How GENB moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

2

Avg Abs. Movement

±7.71%

Positive %

0.0%

Negative %

100.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 06, 2026 ☀ PRE -4.27% open_in_new
May 07, 2026 ☀ PRE -11.14% open_in_new
event

Earnings Count

2

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.71%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 18 →
18
Funds holding
$97036692
Total value held
Buying
15 added · 2 reduced
Blackrock, Inc.
$28003627 NEW BUY
Jpmorgan Chase & Co
$23837165 -52.17%
Nvidia Corp
$14058193 Held
State Street Corp
$8883152 NEW BUY
Morgan Stanley
$6376773 +12.06%

SEC Filing Types

Recent SEC Filings

8 most recent
Form Date Filed View on EDGAR
4 20260903 open_in_new SEC.gov
144 20260902 open_in_new SEC.gov
144 20260901 open_in_new SEC.gov
8-K 20260826 open_in_new SEC.gov
10-Q 20260806 open_in_new SEC.gov
8-K 20260806 open_in_new SEC.gov
SCHEDULE 13G 20260515 open_in_new SEC.gov
SCHEDULE 13G 20260515 open_in_new SEC.gov

Frequently asked about GENB earnings

How much does GENB stock move after earnings? expand_more

Over 2 reports, GENB has moved an average of ±7.71% the session after earnings, closing higher 0.0% of the time.

What was GENB's biggest post-earnings move? expand_more

GENB's largest post-earnings gain on record was -4.27% on Aug 06, 2026, and its largest decline was -11.14% on May 07, 2026.

Where can I find Generate Biomedicines, Inc. Common Stock's SEC filings? expand_more

All of Generate Biomedicines, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers